Chirality of Drugs and Chiral Recognition

[RG #65] Chirality of Drugs and Chiral Recognition

November 1995 - August 1996


Israel Agranat (The Hebrew University of Jerusalem)

The notion of chirality has emerged as a major theme in drug design and discovery. Many of the new chiral drugs are being developed as single enantiomers. Chiral recognition is one of the most significant topics of contemporary stereochemical studies and is an essential component of pharmacological events.




Miklos Simonyi

Hungarian Academy of Sciences
Miklos is a professor in the Department of Molecular Pharmacology at the Central Research Institute for Chemistry, Hungarian Academy of Sciences.